PP01.118 First-line Nivolumab (N) + Ipilimumab (I) + Chemotherapy (C) in Metastatic NSCLC (mNSCLC): CheckMate 9LA 4-Year Clinical Update

This article has no abstract
Epistemonikos ID: d479055adc6122a4c80d5b4a2c58c3ca91e8df2d
First added on: Feb 17, 2025